Registration number: 05262189

Sarang Pharma Limited

Contents

Company Information	1
Balance Sheet	2 to 3
Notes to the Unaudited Financial Statements	2

Sarang Pharma Limited

Company Information

Directors

A Patel M Patel Y Patel

Company secretary

M Patel

Registered office

13 Montpelier Avenue Bexley Kent England DA5 3AP

Accountants

Kishens Limited Chartered Accountants13 Montpelier Avenue Bexley Kent DA5 3AP

Sarang Pharma Limited

(Registration number: 05262189)
Balance Sheet as at 31 March 2025

	2025 £	2024 £
Fixed Assets	2,479,155	2,500,097
Current assets	296,114	558,669
Creditors: Amounts falling due within one year	(201,205)	(362,264)
Net current assets	94,909	196,405
Total assets less current liabilities	2,574,064	2,696,502
Creditors: Amounts falling due after more than one year	(1,240,387)	(1,308,886)
Provisions for liabilities	-	(2,233)
Accruals and deferred income	(1,000)	(1,000)
	1,332,677	1,384,383
Capital and reserves	1,332,677	1,384,383

1	General information

The company is a private company limited by share capital, incorporated in United Kingdom.

The address of its registered office is:
13 Montpelier Avenue
Bexley
Kent
DA5 3AP
England

These financial statements were authorised for issue by the Board on 16 December 2025.

2	Staff numbers

The average number of persons employed by the company (including directors) during the year, was 3 (2024 - 3).

For the financial year ending 31 March 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

•	The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476; and
•	The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

Sarang Pharma Limited

(Registration number: 05262189)
Balance Sheet as at 31 March 2025

These financial statements have been prepared in accordance with the provisions applicable to companies subject to the micro entities regime and delivered in accordance with the provisions applicable to companies subject to the small companies regime. As permitted by section 444 (5A) of the Companies Act 2006, the directors have not delivered to the registrar a copy of the Profit and Loss Account.

Approved and authorised by the Board on 16 December 2025 and signed on its behalf by:
 

......................................... A Patel Director